12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

• Genetic Technologies GENE stock increased by 7.1% to $1.01 during Tuesday's after-market session. The market value of their outstanding shares is at $15.5 million.
• Nymox Pharmaceutical NYMX stock increased by 6.83% to $0.5. The market value of their outstanding shares is at $45.2 million.
• Surrozen SRZN shares rose 6.47% to $0.63. The company's market cap stands at $18.7 million.
• Revelation Biosciences REVB shares moved upwards by 5.5% to $0.27. At the close, Revelation Biosciences's trading volume reached 52.2K shares. This is 3.2% of its average volume over the last 100 days. The company's market cap stands at $6.3 million.
• Clene CLNN stock moved upwards by 5.29% to $1.59. The market value of their outstanding shares is at $117.3 million.
• ContraFect CFRX shares moved upwards by 5.13% to $0.12. ContraFect's trading volume hit 16.2 million shares by close, accounting for 365.5% of its average volume over the last 100 days. The company's market cap stands at $5.4 million.

Losers

• Precigen PGEN shares decreased by 15.5% to $1.85 during Tuesday's after-market session. This security traded at a volume of 351.4K shares come close, making up 44.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $385.0 million.
• Jasper Therapeutics JSPR shares decreased by 14.21% to $1.45. Jasper Therapeutics's trading volume hit 91.7K shares by close, accounting for 3.2% of its average volume over the last 100 days. The company's market cap stands at $53.7 million.
• Zynerba Pharmaceuticals ZYNE shares decreased by 6.1% to $0.59. The market value of their outstanding shares is at $27.8 million.
• Axcella Health AXLA stock declined by 6.07% to $0.56. Axcella Health's trading volume hit 7.7 million shares by close, accounting for 1015.3% of its average volume over the last 100 days. The company's market cap stands at $41.4 million.
• NextGen Healthcare NXGN shares fell 5.45% to $16.15. The company's market cap stands at $1.0 billion. As per the press release, Q3 earnings came out today.
• Kura Oncology KURA stock declined by 5.04% to $13.38. The company's market cap stands at $913.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.